Summary
Human umbilical cord blood (UCB) may be used as an alternative source of bone marrow repopulating cells in allogeneic bone marrow transplantation in children. It has been reported that high numbers of hematopoietic progenitor cells (HPC) from umbilical cord blood may be lost during simple cell-separation techniques. This may seriously hamper the use of UCB as an alternative source of bone marrow repopulating cells. In this study we demonstrate that UCB can be separated into various cell fractions using several cell-separation methods including red blood cell lysis, methylcellulose sedimentation, and density gradients without significant loss of HPC, when cell separations are initiated within 8 h. We demonstrate that UCB contains a high concentration of immature HPC as compared with bone marrow grafts. Using FACS analysis of cells harvested from single colonies derived from single cell- single well-sorted CD34++ CD33− UCB cells, the high frequency of multipotential HPC was illustrated. These results suggest that UCB may contain sufficient HPC for hematopoietic stem cell transplantation in adults.
Similar content being viewed by others
References
O'Reilly RJ (1983) Allogeneic bone marrow transplantation: current status and future directions. Blood 62:941–964
Krivit W, Whitley CB (1987) Bone marrow transplantation for genetic diseases. N Engl J Med 316:1085–1087
Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffman RG, Jacobsen SJ, Marmont AM, McClave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS, Bortin MM (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med 108:806–814
Beatty PG, Clift RA, Michelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA (1985) Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765–771
Beatty PG, Hansen JA, Longton GM et al. (1991) Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51:443–447
Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG (1993) Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 328:437–439
Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828–3832
Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach AD, Douglas G, Cooper S, Falkenburg JHF, Bard J, Boyse EA (1991) Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood cells 17:313–329
Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P et al. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178
Broxmeyer HE, Gluckman E, Auerbach A, Douglas GW, Friedman H, Cooper S, Hangoc G, Kurtzberg J, Bard J, Boyse EA (1990) Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 8:76–91
Vilmer E, Sterkers G, Rahimy C, Denamur E, Elion J, Broyart A, Lescoeur B, Thiercy JM, Gerota J, Blot P (1992) HLA-mismatched cord blood transplantation in a patient with advanced leukemia. Transplantation 53:1155–1157
Van Lemmens P, Plouvier E, Amsallem D, Radacot E, Deschaseaux ML, Schaal JP, Charbord P, Noir A, Herve P (1992) Transplantation of umbilical cord blood in neuroblastoma. Nouv Rev Fr Hematol 34:243–246
Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Smeckpeper B, Shah N, Griffin C, Emanuel PD, Zuckerman KS, Cooper S, Carow C, Bias W, Santos GW (1992) Transplantation of umbilical cord blood after myeloblative therapy: analysis of engraftment. Blood 79:1874–1881
Gluckman E, Thierry D, Brossard Y, Benbunan M, Traineau R, Adam M, Gerotta Y, Auerbach A, Broxmeyer HE (1993) Stem cell harvesting from umbilical cord blood: a new perspective. In: Henon PR, Wunder E (eds) Peripheral blood stem cell autografts. Springer, Berlin Heidelberg New York (in press)
Issaragrisil S, Grilli G, Nothdurft W, Fliedner TM (1984) Characterization of erythroid and granulocyte monocyte progenitors in human cord blood. Scand J Haematol 33:317–322
Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P, et al. (1992) Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109–4113
Hows JM, Bradley BA, Marsh JC, Luft T, Coutinho L, Testa NG, Dexter TM (1992) Growth of human umbilical cord blood in long-term hematopoietic cultures. Lancet 340:73–76
Lu L, Xiao M, Shen RN, Grigsby S, Broxmeyer HE (1993) Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41–48
Author information
Authors and Affiliations
Additional information
This study was supported in part by grants from the J. A. Cohen Institute for Radiopathology and Radiation protection and thePraeventiefonds. J. H. F. Falkenburg is a special fellow of the Royal Netherlands Academy of Arts and Sciences
Rights and permissions
About this article
Cite this article
Falkenburg, J.H.F., van Luxemburg-Heijs, S.A.P., Zijlmans, J.M. et al. Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood. Ann Hematol 67, 231–236 (1993). https://doi.org/10.1007/BF01715053
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01715053